Investor Profile: Hummingbird Ventures

Founded in 2010, Hummingbird Ventures is a global seed-stage investor based in Ghent, London and Istanbul, built around one obsession: outlier founders. Its website states the mission plainly — "We are global investors, looking for outlier founders" — and it deliberately refuses to limit itself to verticals, niches or geographies, preferring to bet on founders "when it isn't obvious, yet." With investments across three continents, it is one of the few genuinely geography-agnostic seed funds in Europe.

The thesis

Hummingbird describes itself as a partner offering "deep conviction from day one" and "low friction" support. Its published operating principles reject check-the-box investing and pedigree-based decision-making in favour of founders on "non-linear journeys" — entrepreneurs willing to challenge the status quo. The firm positions itself as a partner from inception to IPO rather than a one-round investor, providing what it calls "patient and long term capital throughout the near death moments." It emphasises radical candour: sticking up for founders when times are tough rather than when it is easy, and letting entrepreneurs dictate what they need from the relationship instead of the other way around.

Stage, cheque size and sectors

Hummingbird Ventures invests primarily at pre-seed and seed, with typical cheques ranging from around $500,000 to $15 million, and follows on as its companies scale. Its portfolio spans biotech, fintech, healthcare, deep tech, AI, consumer, SaaS and energy, spread across North America, EMEA, APAC and South America. The firm does not publicly disclose a single headline fund size, preferring to talk about its portfolio and approach rather than its capital base. Geography matters less than founder quality: bets are distributed across all four regions, with particular depth in EMEA and North America.

Notable portfolio

The firm's track record includes category-defining names such as Deliveroo, Showpad, Kraken, Peak Games, Gram Games, Amplidata, Shutl and Billiontoone. Activity has remained strong into 2026: in October 2026, Hummingbird led the $30 million Series A of HealthLeap, an AI platform that reads hospital patient records to flag undiagnosed conditions. The firm's crypto-era bets, including early digital-asset companies, sit alongside its healthcare and deep-tech positions, reflecting the thesis that conviction matters more than sector fashion.

Team and how they work

The firm is led by founding partner Barend Van den Brande and partner Firat Ileri, operating with a compact, senior team across its three offices. General enquiries run through [email protected]. The culture the firm projects is deliberately anti-bureaucratic: few processes, direct communication with partners, and a stated willingness to go long on founders whose journeys do not fit a template.

What to know before pitching

Hummingbird is explicit that it does not believe in pedigrees, so a non-traditional background is not a disadvantage — it may be the point. Founders should come prepared with genuine candour about the hard parts of the business: the firm says it wants entrepreneurs who tell it what they need, not the reverse. Warm introductions help at any seed fund, but the open email address and founder-first language suggest cold outreach with a genuinely differentiated story gets read.